IPIKCYA Trademark

Trademark Overview


On Monday, November 6, 2023, a trademark application was filed for IPIKCYA with the United States Patent and Trademark Office. The USPTO has given the IPIKCYA trademark a serial number of 98257328. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, November 6, 2024. This trademark is owned by Ideaya Biosciences, Inc.. The IPIKCYA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes.
ipikcya

General Information


Serial Number98257328
Word MarkIPIKCYA
Filing DateMonday, November 6, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, November 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes.
Translation of Words in MarkThe wording IPIKCYA has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 4, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIdeaya Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Thursday, November 9, 2023NEW APPLICATION ENTERED
Monday, December 4, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 14, 2024ASSIGNED TO EXAMINER
Wednesday, June 19, 2024NON-FINAL ACTION WRITTEN
Wednesday, June 19, 2024NON-FINAL ACTION E-MAILED
Wednesday, June 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 19, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, September 19, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, November 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED